KYORIN Pharmaceutical (4569) · InitiativeRestated
Environmental Measures Led by the Environmental Committee
First written in FY2023. 1 of 2 entries say "Restated". Latest entry: FY2024.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Management and oversight of sustainability-related risks and opportunities through enterprise-wide governanceA theme 268 companies write about · 10 as a headwind · 220 as a tailwind
The whole theme swung hardest in 2022: 2 of 10 companies on the "Worse" side.
75 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 270 threads.Full recordFilings, disclosures and news, newest first
- FY2024RestatedAnnual report
「We have established the Environmental Committee, chaired by the executive officer responsible for the General Affairs Department, to implement and promote environmental measures, including responses to climate change, and built a framework for considering environmental measures and related matters across the group.」
The Company continues to use the Environmental Committee to identify, assess and address climate change risks and opportunities across the group. - FY2023First statedAnnual report
「In April 2023, we established an Environmental Committee chaired by the executive officer responsible for the General Affairs Department and put in place a framework for considering environmental measures.」
An Environmental Committee was established in April 2023 to identify, assess and address climate-related risks and opportunities and other environmental matters.